Kinetics and metabolism of theobromine in male rats - PubMed (original) (raw)
Kinetics and metabolism of theobromine in male rats
M Bonati et al. Toxicology. 1984.
Abstract
On the basis of general pharmacological information (blood cells/plasma partition, plasma protein binding) and using HPLC as the principal analytical method, we investigated the kinetics and metabolism of theobromine (a caffeine metabolite) in male rats after a single dose and after a 2 week chronic application. Doses in both conditions varied between 1 and 100 mg/kg. In in vitro and in vivo the fraction of theobromine unbound to plasma proteins averaged 0.90 over a wide range of concentrations. No significant difference was found in the pharmacokinetic profile of the drug after acute or chronic treatment at different doses except for a reduction in the absorption rate constant as the dose increased. AUC values increased in proportion to the dose. The 2 treatment schedules were also similar as regards metabolism, at least 50% of the administered dose of theobromine being excreted unchanged, and 25% as 6-amino-5-[N-methyl- formylamino ]1-methyluracil. Only at the highest doses was there a tendency for theobromine to accumulate at the expense of its major metabolite (a uracil compound).
Similar articles
- Kinetics and metabolism of theobromine in male and female non-pregnant and pregnant rabbits.
Latini R, Bonati M, Gaspari F, Traina GL, Jiritano L, Bortolotti A, Borzelleca JF, Tarka SM, Arnaud MJ, Garattini S. Latini R, et al. Toxicology. 1984 Apr 16;30(4):343-54. doi: 10.1016/0300-483x(84)90144-6. Toxicology. 1984. PMID: 6729832 - Theobromine kinetics and metabolic disposition.
Tarka SM Jr, Arnaud MJ, Dvorchik BH, Vesell ES. Tarka SM Jr, et al. Clin Pharmacol Ther. 1983 Oct;34(4):546-55. doi: 10.1038/clpt.1983.212. Clin Pharmacol Ther. 1983. PMID: 6617078 - Human disposition and some biochemical aspects of methylxanthines.
Yesair DW, Branfman AR, Callahan MM. Yesair DW, et al. Prog Clin Biol Res. 1984;158:215-33. Prog Clin Biol Res. 1984. PMID: 6396646 Review. - High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.
Säwe J. Säwe J. Clin Pharmacokinet. 1986 Mar-Apr;11(2):87-106. doi: 10.2165/00003088-198611020-00001. Clin Pharmacokinet. 1986. PMID: 3514045 Review.
Cited by
- The relevance of theobromine for the beneficial effects of cocoa consumption.
Martínez-Pinilla E, Oñatibia-Astibia A, Franco R. Martínez-Pinilla E, et al. Front Pharmacol. 2015 Feb 20;6:30. doi: 10.3389/fphar.2015.00030. eCollection 2015. Front Pharmacol. 2015. PMID: 25750625 Free PMC article. - Pharmacokinetics of theobromine and its metabolites in rabbits.
Traina GL, Bonati M. Traina GL, et al. J Pharmacokinet Biopharm. 1985 Feb;13(1):41-53. doi: 10.1007/BF01073655. J Pharmacokinet Biopharm. 1985. PMID: 4020621 - Chemical Composition and Hypotensive Effect of Campomanesia xanthocarpa.
Sant'Anna LS, Merlugo L, Ehle CS, Limberger J, Fernandes MB, Santos MC, Mendez ASL, Paula FR, Moreira CM. Sant'Anna LS, et al. Evid Based Complement Alternat Med. 2017;2017:1591762. doi: 10.1155/2017/1591762. Epub 2017 May 11. Evid Based Complement Alternat Med. 2017. PMID: 28584558 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources